ANELLOGY

Serial Number 90525511
602

Registration Progress

Application Filed
Feb 11, 2021
Under Examination
Sep 13, 2022
Approved for Publication
Jul 19, 2022
Published for Opposition
Jul 19, 2022
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ANELLOGY
Previous Owner: Ring Therapeutics, Inc.
Classes: 042

Trademark Image

ANELLOGY

Basic Information

Serial Number
90525511
Filing Date
February 11, 2021
Published for Opposition
July 19, 2022
Abandonment Date
May 30, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jun 14, 2023
Classes
042

Rights Holder

Ring Therapeutics, Inc.

03
Address
55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Ownership History

Ring Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Ring Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Christina M. Licursi

Application History

34 events
Date Code Type Description Documents
Jun 14, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jun 14, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Jun 14, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jun 14, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 29, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 29, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Nov 29, 2022 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Nov 29, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 29, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Nov 29, 2022 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Oct 21, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 6, 2022 IUAF S USE AMENDMENT FILED Loading...
Oct 21, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 6, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 13, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 19, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 19, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 29, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 16, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 27, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 27, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 27, 2022 ALIE A ASSIGNED TO LIE Loading...
May 23, 2022 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Apr 28, 2022 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Apr 28, 2022 GNFR O FINAL REFUSAL E-MAILED Loading...
Apr 28, 2022 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 7, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 7, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 7, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 20, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 20, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 20, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 7, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 16, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 042
Product development for others in the field of biotechnology and development of pharmaceuticals and therapeutic agents; research and development of therapeutics related to the discovery, capture, and analysis of data in the field of anelloviruses; providing scientific laboratory services for the discovery, capture, and analysis of data in the field of anelloviruses; providing temporary use of non-downloadable software for the discovery, capture, and analysis of data in the field of anelloviruses
First Use Anywhere: Nov 7, 2021
First Use in Commerce: Nov 7, 2021

Classification

International Classes
042